Johnson & Johnsonwill need to pay more than $300m in penalties for deceptively marketing subsidiary Ethicon Inc.’s pelvic mesh products, a California appeals court ruled last week.
The ruling upholds $302m of a $344m verdict against the company handed down by a California trial court. The remaining...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?